Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-03

FDA Approved: NALOXONE HYDROCHLORIDE INJECTION, USP, AUTO-INJECTOR — Supplemental Application (Kaleo, Inc.)

View source ↗

Summary

FDA approved Kaleo, Inc.'s supplemental application for Naloxone Hydrochloride Injection, USP, Auto-Injector. The product is intended for emergency treatment of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NALOXONE HYDROCHLORIDE INJECTION, USP, AUTO-INJECTOR (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE INJECTION, USP, AUTO-INJECTOR (NALOXONE HYDROCHLORIDE)